Lista de obras - Osvaldo Martinez - Dominio Público Uruguay

A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.

artículo científico publicado en 2013

Characterization of a recombinant Yersinia enterocolitica lipoprotein; implications for its role in autoimmune response against thyrotropin receptor.

artículo científico publicado en 2004

Contrasting effects of IG20 and its splice isoforms, MADD and DENN-SV, on tumor necrosis factor alpha-induced apoptosis and activation of caspase-8 and -3

artículo científico publicado en 2001

Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis

artículo científico publicado en 2005

Corrigendum: Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

artículo científico publicado en 2012

DC-SIGN, but not sDC-SIGN, can modulate IL-2 production from PMA- and anti-CD3-stimulated primary human CD4 T cells

artículo científico publicado en 2005

Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses.

artículo científico publicado en 2006

Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model

artículo científico publicado en 2004

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

artículo científico publicado en 2006

Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

artículo científico publicado en 2007

Ebola virus exploits a monocyte differentiation program to promote its entry

artículo científico publicado en 2013

Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry.

artículo científico publicado en 2011

Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.

artículo científico publicado en 2007

Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells

artículo científico publicado en 2011

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse

artículo científico publicado en 2006

IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC

artículo científico publicado en 2004

IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs

artículo científico publicado en 2004

Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.

artículo científico publicado en 2011

Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses

artículo científico publicado en 2012

Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus

artículo científico publicado en 2010

Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection

artículo científico publicado en 2010

Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.

artículo científico publicado en 2009

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

artículo científico publicado en 2008

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

artículo científico publicado en 2008

Targeted Delivery of Anti-CTLA-4 Antibody Downregulates T Cell Function in Vitro and in Vivo ⬇️

artículo científico publicado el 1 de noviembre de 2001

The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge

artículo científico publicado en 2012

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus

artículo científico publicado en 2007

Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.

artículo científico publicado en 2009

Lista de obras de Osvaldo Martinez

A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner.

Characterization of a recombinant Yersinia enterocolitica lipoprotein; implications for its role in autoimmune response against thyrotropin receptor.

Contrasting effects of IG20 and its splice isoforms, MADD and DENN-SV, on tumor necrosis factor alpha-induced apoptosis and activation of caspase-8 and -3

Correlation of disease evolution with progressive inflammatory cell activation and migration in the IL-4 transgenic mouse model of atopic dermatitis

Corrigendum: Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors

DC-SIGN, but not sDC-SIGN, can modulate IL-2 production from PMA- and anti-CD3-stimulated primary human CD4 T cells

Diversity in the complementarity-determining region 3 (CDR3) of antibodies from mice with evolving anti-thyroid-stimulating hormone receptor antibody responses.

Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation

Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1.

Ebola virus exploits a monocyte differentiation program to promote its entry

Ebola virus failure to stimulate plasmacytoid dendritic cell interferon responses correlates with impaired cellular entry.

Ebola virus-like particle-induced activation of NF-kappaB and Erk signaling in human dendritic cells requires the glycoprotein mucin domain.

Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells

Generation and characterization of human monoclonal neutralizing antibodies with distinct binding and sequence features against SARS coronavirus using XenoMouse

IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC

IG20, in contrast to DENN-SV, (MADD splice variants) suppresses tumor cell survival, and enhances their susceptibility to apoptosis and cancer drugs

Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.

Influenza Human Monoclonal Antibody 1F1 Interacts with Three Major Antigenic Sites and Residues Mediating Human Receptor Specificity in H1N1 Viruses

Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus

Nanodisc-incorporated hemagglutinin provides protective immunity against influenza virus infection

Neutralizing anti-influenza virus monoclonal antibodies: therapeutics and tools for discovery.

Neutralizing antibodies derived from the B cells of 1918 influenza pandemic survivors.

Recombinant Newcastle disease virus as a vaccine vector for cancer therapy

Targeted Delivery of Anti-CTLA-4 Antibody Downregulates T Cell Function in Vitro and in Vivo ⬇️

The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge

Use of reverse genetics to enhance the oncolytic properties of Newcastle disease virus

Zaire Ebola virus entry into human dendritic cells is insensitive to cathepsin L inhibition.